Error loading player: No playable sources found

21B76822-0EB3-4420-8048-2CD4C38C909F

Opening Remarks and Silent Struggles: Bridging Gaps in PTSD Care for a Holistic Healing Journey

Date
November 15, 2024
Explore related products in the following collection:

Explore the frontiers of PTSD care in this session, which will shine a spotlight on the existing gaps in current PTSD treatment modalities, providing a critical examination of where the gaps lie and their impact on individuals. Delve into the promising realm of emerging management strategies as we discuss innovative approaches that hold the potential to reshape and enhance PTSD care.

Speakers

Speaker Image for Jeremy Schreiber
Jeremy A. Schreiber, MSN, APRN, PMHNP-BC
Speaker Image for Chelsie Monroe
Chelsie Monroe, MSN, APN, PMHNP-BC

Related Products

Thumbnail for Casting a Wide Net: Identifying and Treating Tardive Dyskinesia in Diverse Patient Populations
Casting a Wide Net: Identifying and Treating Tardive Dyskinesia in Diverse Patient Populations
This session will focus on the importance of screening in older patients, with consideration of changes in patient insight across disease states and over time…
Thumbnail for The Patient Journey Through Bipolar II Depression
The Patient Journey Through Bipolar II Depression
This presentation follows the journey of a patient with bipolar II depression and explores an approved treatment option. This non-CME educational program is sponsored by Intra-Cellular Therapies, Inc…
Thumbnail for Steering Through Anxiety: Evidence-Based Navigation for Anxiety Disorders
Steering Through Anxiety: Evidence-Based Navigation for Anxiety Disorders
Exploring evidence-based approaches to anxiety disorders, this session equips advanced practice providers with the skills to differentiate between anxiety subtypes and implement effective treatment strategies…
Thumbnail for Charting Paths: Evidence-Based Decisions in MDD Treatment Beyond the First Line
Charting Paths: Evidence-Based Decisions in MDD Treatment Beyond the First Line
When a patient with MDD does not respond to a first-line agent, it can be difficult to decide whether to switch or augment therapy…